The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study.

Johanna HolmgrenAnna FröborgIsabella VisuriJonas HalfvarsonHenrik HjortswangPontus KarlingPär MyrelidOla Olénnull nullJonas F LudvigssonOlof Grip

Published in: Inflammatory bowel diseases (2022)

In routine clinical practice in Sweden, the incidence rate of serious infection among IBD patients did not increase with anti-TNF therapy. Instead, serious infections seemed to decrease more than 1 year after initiation of anti-TNF treatment.

Keyphrases

clinical practice
rheumatoid arthritis
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
risk factors
prognostic factors
stem cells
bone marrow
ulcerative colitis
smoking cessation